RCAG
DXCM icon

Rehmann Capital Advisory Group’s DexCom DXCM Stock Holding History

Rehmann Capital Advisory Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Buy
4,854
+1,174
+32% +$81.8K 0.02% 547
2025
Q4 		$245K Buy
+3,680
New +$238K 0.01% 578
2025
Q3 		– Sell
-2,437
Closed -$213K – 646
2025
Q2 		$213K Buy
+2,437
New +$191K 0.01% 569
2024
Q3 		– Sell
-2,388
Closed -$271K – 597
2024
Q2 		$271K Buy
2,388
+7
+0.3% +$885 0.02% 478
2024
Q1 		$330K Sell
2,381
-99
-4% -$12.4K 0.02% 426
2023
Q4 		$308K Sell
2,480
-76
-3% -$7.76K 0.03% 426
2023
Q3 		$238K Sell
2,556
-113
-4% -$12.7K 0.02% 453
2023
Q2 		$343K Sell
2,669
-556
-17% -$67.2K 0.03% 391
2023
Q1 		$375K Sell
3,225
-172
-5% -$19.3K 0.04% 364
2022
Q4 		$385K Buy
3,397
+64
+2% +$7.03K 0.04% 346
2022
Q3 		$268K Buy
3,333
+119
+4% +$10.1K 0.03% 410
2022
Q2 		$240K Sell
3,214
-222
-6% -$20.3K 0.03% 425
2022
Q1 		$439K Buy
3,436
+20
+0.6% +$2.19K 0.04% 331
2021
Q4 		$459K Sell
3,416
-244
-7% -$35.1K 0.04% 328
2021
Q3 		$500K Sell
3,660
-28
-0.8% -$3.53K 0.05% 316
2021
Q2 		$395K Sell
3,688
-3,092
-46% -$297K 0.04% 366
2021
Q1 		$346K Buy
6,780
+1,524
+29% +$143K 0.04% 374
2020
Q4 		$613K Buy
5,256
+1,668
+46% +$149K 0.07% 230
2020
Q3 		$370K Sell
3,588
-408
-10% -$42.6K 0.05% 288
2020
Q2 		$405K Buy
3,996
+4
+0.1% +$358 0.06% 275
2020
Q1 		$269K Buy
+3,992
New +$248K 0.04% 308
2019
Q3 		– Sell
-5,304
Closed -$199K – 1762
2019
Q2 		$199K Sell
5,304
-552
-9% -$17.4K 0.02% 437
2019
Q1 		$174K Sell
5,856
-1,652
-22% -$58.1K 0.02% 439
2018
Q4 		$225K Sell
7,508
-1,532
-17% -$48.6K 0.03% 231
2018
Q3 		$323K Sell
9,040
-628
-6% -$19.5K 0.04% 287
2018
Q2 		$230K Sell
9,668
-732
-7% -$15.5K 0.03% 340
2018
Q1 		$193K Buy
+10,400
New +$154K 0.03% 381

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rehmann Capital Advisory Group's DXCM Position: Q1 2026 in Review

Rehmann Capital Advisory Group increased its DexCom (DXCM) stake by 32% in Q1 2026, buying an estimated $81.8K and bringing the position to 4,854 shares worth $305K. The position accounts for 0.02% of the portfolio, ranked #547.

Rehmann Capital Advisory Group first reported a position in DXCM in Q1 2018 and has held it in 27 quarters since. The position peaked at $613K in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Rehmann Capital Advisory Group held 4,854 shares of DexCom worth $305K as of Q1 2026.
  • Rehmann Capital Advisory Group bought 1,174 DexCom shares in Q1 2026, an estimated $81.8K.
  • DexCom made up 0.02% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #547 holding.
  • Rehmann Capital Advisory Group first reported a position in DexCom in Q1 2018 and has held it in 27 quarters since.
  • Rehmann Capital Advisory Group's DexCom position peaked at $613K in Q4 2020.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.